(4S) - 4 - 4-cyano-2 - (methylsulfonyl) phenyl - 3,6-dimethyl-2-oxo-1 - 3 - (trifluoromethyl) phenyl - 1,2,3,4-tetrahydropyrimidine-5-carbonitrile

摘要

Problem to be solved: to provide a novel and improved manufacturing method of a compound for treatment of disease and a crystal form.The compound of formula (I) is characterized in that the X-ray diffraction pattern of the compound exhibits peak peak values of 2 theta angles at 7.5, 12.4, 15.1, 18.5, 18.7, 22.9, 24.7, and 26.5.No selection